This study provides a new direction for the treatment of hepatoma (utilizing the inhibitory effects of lingonberry extract on the chemokine CXCL3), offers new insight into the study of lingonberry’s antihepatoma properties, and provides a basis for the development of pilot antitumor drugs. Here, CXCL3 is linked to hepatocellular carcinoma.